First year impact report published for the North West London Clinical Trials Alliance
The first year impact report for the North West London Clinical Trials Alliance has been published.
The report explores the achievements of the Alliance so far and looks ahead to how future research can be supported.
"The main aim of the Alliance now is to work in a completely regional approach with the life sciences industry"
Dr Suki Balendra, Life Sciences Lead at the NIHR Clinical Research Network North West London, said:
"The Alliance, that was born out of necessity in the pandemic, is now a great opportunity for us to learn the lessons of our success – bottling the formula we have developed to tackle COVID and applying it to all other disease areas.
"North West London is one of the most diverse and vibrant areas of our capital. The main aim of the Alliance now is to work in a completely regional approach with the life sciences industry and give patients the opportunity to take part in trials relevant to the population of North West London."
The North West London Clinical Trials Alliance is a collaboration between the NIHR Clinical Research Network North West London, the local primary care network, Central London Community Healthcare NHS Trust, and the clinical research facilities (CRFs) hosted by:
- Chelsea and Westminster Hospital NHS Foundation Trust
- Imperial College Healthcare NHS Trust
- London North West University Healthcare NHS Trust
The Alliance is dedicated to delivering commercial and non-commercial sponsored clinical trials – utilising existing and purpose-designed facilities to successfully deliver both early and late-phase research.
Key successes in the report:
- Successfully delivered 8 COVID-19 vaccine trials, 100% time-to-target
- Recruited over 1,600 participants
- Across 3 Clinical Research Facilities and in primary care settings
- Resulting in 4 COVID-19 vaccines approved for use in the UK
Read the full first year report of the North West London Clinical Trials Alliance.
